The efficacy and safety of novel anti-obesity therapies

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2015, Vol 32, Issue 3

Abstract

Obesity is a chronic disease with a high prevalence in both developed and developing countries. Lifestyle interventions, such as restricting calorie consumption and increasing physical activity, continue to be the cornerstone of weight-reduction programs. Novel anti-obesity drug therapies are currently gaining in importance. These include lorcaserin (a selective serotonin agonist), phentermine/topiramate combination, naltrexone/bupropion combination (acting on the hypothalamus), and liraglutide, an established anti-diabetic agent which suppresses the appetite. This is a brief review of the evidence on the role of these anti-obesity drugs in the management of obesity.

Authors and Affiliations

A. PAPAZAFIROPOULOU, N. PAPANAS

Keywords

Related Articles

B-chronic lymphocytic leukemia - latest developments

B-chronic lymphocytic leukemia (CLL) is the most common type of leukemia in western countries. Research during the last two decades has contributed to better understanding of the biology of the disease. Two subtypes of C...

The factors contributing to "epidemiological transition" and its consequences in the organization of health care services and the development of health policy

This paper addresses the mechanisms involved in, and the indices that demonstrate, changing patterns of diseases, and explores the reforms in the health care systems which are necessary to cope with the changes. The epid...

The practice of medicine in relation to the limitation of availability of financial resources

It is generally accepted that both the physician and the health system should aim to defend the health of each patient individually and protect the health of the population in general. Nowadays, however, the cost of supp...

ΒΙΒΛΙΟΠΑΡΟΥΣΙΑΣΗ

Βασικές, Ανώτερες και Εξειδικευμένες Νοσηλευτικές Δεξιότητες. Επιμέλεια: G.J. Baltopoulos

Download PDF file
  • EP ID EP142868
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

A. PAPAZAFIROPOULOU, N. PAPANAS (2015). The efficacy and safety of novel anti-obesity therapies. Αρχεία Ελληνικής Ιατρικής, 32(3), 295-301. https://europub.co.uk./articles/-A-142868